Journal of Clinical Oncology

Erratum: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group

B Benjamin J. Huang (2Division of Oncology, Department of Pediatrics, University of California San Francisco, San Francisco, CA) L Lauren K. Meyer T Todd A. Alonzo (Univ. of Southern California Keck School of Medicine, Los Angeles, CA) Y Yi-Cheng Wang A Adam J. Lamble R Rhonda E. Ries W Weijie Wang B Betsy Hirsch (7University of Minnesota Cancer Center, Minneapolis, United States) G Gordana Raca (8Children's Hospital Los Angeles, Los Angeles, United States) X Xiaotu Ma (1Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN) A Alan S. Gamis R Richard Aplenc E E. Anders Kolb T Todd M. Cooper (25Cancer and Blood Disorders Center, Seattle Children’s Hospital, Seattle, WA) K Katherine Tarlock (3Seattle Children's Hospital, Division of Hematology and Oncology, Seattle, United States) M Michael R. Loken (Hematologics, Inc, Seattle, WA) S Soheil Meshinchi J Joseph H. Chewning (12Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL) W William G. Woods J John T. Horan
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 24
Published August 20, 2025
Pages 2757-2757
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (20)

B

Benjamin J. Huang

2Division of Oncology, Department of Pediatrics, University of California San Francisco, San Francisco, CA

L

Lauren K. Meyer

T

Todd A. Alonzo

Univ. of Southern California Keck School of Medicine, Los Angeles, CA

Y

Yi-Cheng Wang

A

Adam J. Lamble

R

Rhonda E. Ries

W

Weijie Wang

B

Betsy Hirsch

7University of Minnesota Cancer Center, Minneapolis, United States

G

Gordana Raca

8Children's Hospital Los Angeles, Los Angeles, United States

X

Xiaotu Ma

1Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN

A

Alan S. Gamis

R

Richard Aplenc

E

E. Anders Kolb

T

Todd M. Cooper

25Cancer and Blood Disorders Center, Seattle Children’s Hospital, Seattle, WA

K

Katherine Tarlock

3Seattle Children's Hospital, Division of Hematology and Oncology, Seattle, United States

M

Michael R. Loken

Hematologics, Inc, Seattle, WA

S

Soheil Meshinchi

J

Joseph H. Chewning

12Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL

W

William G. Woods

J

John T. Horan

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001